Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients

INTRODUCTION: Clinical trials (CT) on triple therapy against HCV infection in HIV-infected patients including TVR plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than with PR alone. This study was aimed to evaluate the efficacy and safety of triple thera...

Descripción completa

Detalles Bibliográficos
Autores principales: De Los Santos, Ignacio, Montes, Marisa, Sanz-Moreno, Jose, De Miguel, Julio, Sanz-Sanz, Jesus, Gaspar, Gabriel, Perez-Caballero, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Session – Abstract P101
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224774/
https://www.ncbi.nlm.nih.gov/pubmed/25394137
http://dx.doi.org/10.7448/IAS.17.4.19633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224774/
https://www.ncbi.nlm.nih.gov/pubmed/25394137
http://dx.doi.org/10.7448/IAS.17.4.19633

Ejemplares similares